肿瘤易感性基因标志物项目或简称CGEMS是国家肿瘤研究所和哈佛大学的一个合作项目。
The Cancer Genetic Markers of Susceptibility or CGEMS is collaboration between National Cancer Institute and Harvard.
还有一个需要，以确定疾病的易感性的预后指标，生物标志物来监测疾病的进展和改进的技术新疗法的有效性。
There is also a need to identify prognostic markers of disease susceptibility, biomarkers of disease progression and improved technologies to monitor the effectiveness of new therapies.
还有一个需要，以确定疾病的易感性的预后指标，生物标志物来监测疾病的进展和改进的技术新疗法的有效性。
There is also a need to identify prognostic markers of disease susceptibility, biomarkers of disease progression and improved technologies to monitor the effectiveness of new therapies.
应用推荐